Shinichiro Nakajima, MD, PhD | Psychiatrist.com

Original Research

Early Improvements Predict Treatment Response in Alzheimer's

February 11, 2020

Can overall response to antipsychotics be predicted by early improvements in individual symptoms among Alzheimer's disease patients? The current report analyzes the CATIE-AD phase 1 dataset in an attempt...

Tomoyuki Nagata, Shunichiro Shinagawa, Kazunari Yoshida, et al

Original Research

Anosognosia in MCI and AD

October 10, 2017

Although anosognosia—or impaired illness awareness—is common in Alzheimer's disease, it occurs less frequently in mild cognitive impairment. Read this article to learn if anosognosia in patients with mild cognitive...

Bruce G. Pollock, Philip Gerretsen, Jun Ku Chung, et al

Article

Hyperprolactinemia in Older Patients With Schizophrenia

December 28, 2016

Since older patients are known to be hypersensitive to antipsychotics, are they vulnerable to developing hyperprolactinemia with these drugs? This post hoc study looked at whether the dopamine D2/3...

Benoit H. Mulsant, Hiroyuki Uchida, Bruce G. Pollock, et al

Article

Whether to Increase or Maintain Dosage of Mirtazapine in Early Nonimprovers With Depression

April 22, 2015

Hiroyuki Uchida, Shinichiro Nakajima, Takayuki Abe, et al

Letter to the Editor

Selective Serotonin Reuptake Inhibitor-Induced Spermatorrhea in 2 Patients

August 15, 2009

Hiroyuki Uchida, Shinichiro Nakajima, Koichiro Watanabe, et al